Future research in the field of cationic amphiphilic drugs focuses on understanding the molecular mechanisms underlying their toxic effects. Advances in biomarkers for early detection of CAD-induced toxicity and the development of computational models for predicting drug interactions are also promising areas. Additionally, the exploration of novel drug formulations and delivery systems aims to enhance therapeutic efficacy while minimizing adverse effects.
